Literature DB >> 3561043

A short test of mental status: description and preliminary results.

E Kokmen, J M Naessens, K P Offord.   

Abstract

A short test of mental status (encompassing about 5 minutes) was administered to 93 consecutive neurologic outpatients without dementia, 67 outpatients with Alzheimer-type dementia, and 20 outpatients with dementia of miscellaneous causes. The mean scores for patients with Alzheimer-type dementia were lower than those for the nondemented patients in the total scoring and on all subtests (P less than 0.001). When a total score of 29 or less (maximal attainable score, 38) was used as a screen for dementia, a sensitivity of 92% and a specificity of 91% were reached. For patients older than 60 years of age, a score of 29 or less resulted in a sensitivity of 95% and a specificity of 88%. Thus, in general, this easily administered test distinguishes demented from nondemented patients, but it should not be used as the sole means of diagnosing dementia.

Entities:  

Mesh:

Year:  1987        PMID: 3561043     DOI: 10.1016/s0025-6196(12)61905-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  85 in total

1.  Clinical and imaging features of Othello's syndrome.

Authors:  J Graff-Radford; J L Whitwell; Y E Geda; K A Josephs
Journal:  Eur J Neurol       Date:  2011-04-25       Impact factor: 6.089

Review 2.  Mild cognitive impairment in older adults.

Authors:  Yonas E Geda
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

3.  Lower Vitamin B12 Level at Multiple System Atrophy Diagnosis Is Associated With Shorter Survival.

Authors:  Stuart J McCarter; Elizabeth A Coon; Rodolfo Savica; Erik K St Louis; James H Bower; Eduardo E Benarroch; Paola Sandroni; Phillip Low; Wolfgang Singer
Journal:  Mov Disord       Date:  2020-04-22       Impact factor: 10.338

4.  MRI findings in benign multiple sclerosis are variable.

Authors:  Sean J Pittock; John H Noseworthy; Moses Rodriguez
Journal:  J Neurol       Date:  2006-08-29       Impact factor: 4.849

5.  What is the quality of life in the oldest old?

Authors:  Maria I Lapid; Teresa A Rummans; Bradley F Boeve; Joan K McCormick; V Shane Pankratz; Ruth H Cha; Glenn E Smith; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen
Journal:  Int Psychogeriatr       Date:  2011-02-01       Impact factor: 3.878

6.  Imaging correlates of posterior cortical atrophy.

Authors:  Jennifer L Whitwell; Clifford R Jack; Kejal Kantarci; Stephen D Weigand; Bradley F Boeve; David S Knopman; Daniel A Drubach; David F Tang-Wai; Ronald C Petersen; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2006-06-23       Impact factor: 4.673

7.  Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy.

Authors:  Wendy A Vanvoorst; Melanie C Greenaway; Bradley F Boeve; Robert J Ivnik; Joseph E Parisi; J Eric Ahlskog; David S Knopman; Dennis W Dickson; Ronald C Petersen; Glenn E Smith; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2007-10-31       Impact factor: 4.891

8.  Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Authors:  Anna Pink; Scott A Przybelski; Janina Krell-Roesch; Gorazd B Stokin; Rosebud O Roberts; Michelle M Mielke; Kathleen A Spangehl; David S Knopman; Clifford R Jack; Ronald C Petersen; Yonas E Geda
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-08-31       Impact factor: 2.198

9.  Handwriting as a gauge of cognitive status: a novel forensic tool for posthumous evaluation of testamentary capacity.

Authors:  Paola Fontana; Francesca Dagnino; Leonardo Cocito; Maurizio Balestrino
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

10.  The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis.

Authors:  B K Kleinschmidt-DeMasters; Denise M Damek
Journal:  J Neurooncol       Date:  2009-07-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.